Getting rid of steroids in pediatric solid-organ transplantation?

Pediatric Transplantation

Volumn 8, Issue 6, 2004, Pages 526-530

  Reding, Raymond ^a   Webber, Steven A ^b   Fine, Richard ^c  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

BONE NECROSIS; CATARACT; CHILD; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EDITORIAL; GRAFT REJECTION; GRAFT SURVIVAL; GROWTH RETARDATION; HEART TRANSPLANTATION; HUMAN; HYPERLIPIDEMIA; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MOON FACE; NEPHROTOXICITY; OBESITY; ORGAN TRANSPLANTATION; OSTEOPENIA; PEDIATRICS; RECIPIENT; RISK BENEFIT ANALYSIS; SIDE EFFECT; TRANSPLANTATION TOLERANCE;

CHILD; GLUCOCORTICOIDS; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY;

EID: 11144245097     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2004.00226.x     Document Type: Editorial

References (25)

1. FINE RN, OTTE JB, TEJANI A. Corticosteroid elimination in pediatric solid organ transplantation. Pediatr Transplant 1998: 2: 3-5.
2. STARZL TE, MARCHIORO TL, ROWLANDS DT, et al. Immunosuprression after experimental and clinical homotransplantation of the liver. Ann Surg 1964: 160: 411-439.
3. ETTENGER R. The practical problems of prednisone in pediatric renal transplantation. Transplant Proc 2001: 33: 989-991.
4. FINE RN. Growth following solid-organ transplantation. Pediatr Transplant 2002: 6: 47-52.
5. HERON TG, SMALLWOOD GA, OAKLEY B, et al. Autoimmune hepatitis following liver transplantation: Relationship to recurrent disease and steroid weaning. Transplant Proc 2002: 34: 3311-3312.
6. BERKI T, TAVAKOLI A, NAGY KK, NAGY G, NÉMETH P. Alterations of glucocorticoid receptor expression during glucocorticoid hormone therapy in renal transplant patients. Transpl Int 2002: 15: 132-138.
7. KOSHIBA T, VAN DAMME B, JI P, et al. Addition of steroids blocks the tolerogenic potential of donor-specific blood transfusion. Transplant Proc 2002: 33: 375-376.
8. WANG C, SUN J, SHEIL AG, MCCAUGHAN GW, BISHOP GA. A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation 2001: 72: 44-51.
9. SARWAL MM, YORGIN PD, ALEXANDER S, et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001: 72: 13-21.
10. SARWAL MM, VIDHUN JR, ALEXANDER SR, SATTERWHITE T, MILLAN M, SALVATIERRA O. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 2003: 76: 1331-1339.
11. CHAKRABARTI P, WONG HY, SCANTLEBURY VP, et al. Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 2000: 70: 760-764.
12. RADLEY-SMITH RC, YACOUB MH. Long-term results of pediatrie heart transplantation. J Heart Lung Transplant 1992: 11: S277-S281.
13. RAZZOUK AJ, CHINNOCK RE, GUNDRY SR, et al. Transplantation as a primary treatment for hypoplastic left heart syndrome: Intermediate-term results. Ann Thorac Surg 1996: 62: 1-7.
14. LEONARD H, HORNUNG T, PARRY G, DARK JH. Pediatric cardiac transplant: Results using a steroid-free maintenance regimen. Pediatr Transplant 2003: 7: 59-63.
15. FULLERTON DA, CAMPBELL DN, JONES SD, et al. Heart transplantation in children and young adults: Early and intermediate-term results. Ann Thorac Surg 1995: 59: 804-811.
16. CANTER CE, MOORHEAD S, SATZ JE, HUDDLESTON CB, SPRAY TL. Steroid withdrawal in the pediatric heart transplant recipient initially treated with triple immunosuppression. J Heart Lung Transplant 1994: 13: 74-79.
17. WEBBER SA. 15 years of pediatric heart transplantation at the University of Pittsburgh: Lessons learned and future prospects. Pediatr Transplant 1997: 1: 8-21.
18. KOBASHIGAWA JA, STEVENSON LW, BROWNfiELD ED, et al. Initial success of steroid weaning late after heart transplantation. J Heart Lung Transplant 2004: 11: 428-430.
19. BOUCEK MM, EDWARDS LB, KECK BM, et al. The registry of the International Society for Heart and Lung Transplantation: Fifth official pediatric report - 2001 to 2002. J Heart Lung Transplant 2002: 21: 827-840.
20. WEBBER SA, NAFTEL DC, PARKER J, et al. Late rejection episodes more than one year after pediatric heart transplantation: Risk factors and outcomes. J Heart Lung Transplant 2003: 22: 869-875.
21. REDING R. Steroid withdrawal in liver transplantation. Benefits, risks, and unanswered questions. Transplantation 2000: 70: 405-410.
22. VO THI DIEM H, SOKAL E, JANSSEN M, OTTE JB, REDING R. Steroid withdrawal after pediatric liver transplantation. A long-term follow-up study in 109 recipients. Transplantation 2003: 75: 1664-1670.
23. JAIN A, MAZARIEGOS G, KASHYAP R, et al. Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation. Pediatr Transplant 2001: 5: 93-98.
24. MAZARIEGOS GV, SINDHI R, SMITH A, McGHEE W, FUNG JJ, REYES J. Rabbit anti-thymocyte globulin (rATG) induction therapy for pediatric steroid free liver transplantation. Am J Transplant 2003: 3(S5): 453.
25. REDING R, GRAS J, SOKAL E, OTTE JB, DAVIES HFS. Steroid-free liver transplantation in children. Lancet 2003: 362: 2068-2070.